Ehlers, Lars <br/><br/>
National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.  [electronic resource] 

 -  CNS drugs  2008 
 - 73-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1172-7047 
<br/><br/><label>Standard No.: </label>10.2165/00023210-200822010-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Brain Ischemia--complications<br/>Budgets<br/>Cerebral Hemorrhage--epidemiology<br/>Cost of Illness<br/>Cost-Benefit Analysis<br/>Denmark--epidemiology<br/>Drug Costs<br/>Drug Utilization<br/>Female<br/>Fibrinolytic Agents--economics<br/>Humans<br/>Male<br/>Models, Economic<br/>Quality-Adjusted Life Years<br/>Randomized Controlled Trials as Topic<br/>Stroke--drug therapy<br/>Telemedicine--economics<br/>Tissue Plasminogen Activator--economics